StockIQpro
NASDAQ:GCTK

Glucotrack, Inc.

Track all markets on TradingView
Track all markets on TradingView

Glucotrack, Inc. reported net income of −$19.4M in fiscal 2025. Free cash flow was −$15.3M, and the diluted share count rose 11186.5%.Summary generated from Glucotrack, Inc.'s SEC filings. Latest annual report filed Mar 30, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow−$15.3M
FCF marginn/a
Share count change+11186.5%

Financials

Fiscal years, $M
Item20212022202320242025
Revenuen/an/an/an/an/a
Operating income−4−4−7−15−16
Net income−4−4−7−23−19
Free cash flow−4−4n/a−13−15

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus